Objective. This study aimed to investigate the mechanisms of action of WEB-2170, an inverse agonist of platelet-activating factor receptor, capable of inducing apoptosis in human acute myelogenous leukemia (AML) cells. Material and Methods. Gene expression profiling followed by cytofluorimetric, morphologic, and biologic analyses were used to monitor WEB-2170 effects in AML cell lines (ie, NB4, KG1, NB4-MR4, THP1, and U937) and blasts from patients with different AML (M0LM5) subtypes. PTEN silencing with small interfering RNA was also performed. Results. We have demonstrated that drug-mediated cytostasis/apoptosis in NB4 cells is characterized by upregulation of cyclin G2, p21/WAF1, NIX, TNFLa, and PTEN expression, and downregulation of cyclin D2 and BCL2 expression. We observed an increase in PTEN protein accompanied by a decrease in phospho-extracellular signal-regulated kinase 2 (ERK2) and phospho-AKT, and by forkhead box O3a (FOXO3a) cytoplasmic-nuclear translocation; the mitochondrial cytochrome C release and PARP cleavage marked the late apoptotic steps. We have found that WEB-2170 triggered apoptosis in NB4, KG1, and NB4-MR4 cells where PTEN was expressed, but not in THP1 and U937 cells where PTEN was absent. Finally, we show that PTEN silencing in NB4 cells by PTEN-specific small interfering RNA resulted in a significant reduction of drug-induced apoptosis. Conclusion. We demonstrated that WEB-2170 is a powerful antileukemic agent with interesting translational opportunities to treat AML and described mechanisms of drug-induced intrinsic and extrinsic apoptosis both in AML cell lines and blasts from AML patients by addressing PTEN as the master regulator of the whole process. Ó 2009 ISEH -Society for Hematology and Stem Cells. Published by Elsevier Inc.
, thus providing additional tools for cancer therapy [10] . Indeed, epigenetic modulators are functional to set up an environment permissive for cell differentiation and/or apoptosis, but may not always be sufficient themselves to trigger these processes without the cooperation of other proactive signals. It is of great interest, therefore, to identify and characterize new agents capable of inducing cytostasis, differentiation, and apoptosis in AML cells, and supporting the action of epigenetic modulators and conventional chemotherapy so as to decrease effective therapeutic doses and untoward consequences to the host.
We previously showed that WEB-2170 da ligand of platelet-activating factor receptor (PAF-r) originally synthesized from an anxiolytic triazolobenzodiazepine [11, 12] d could also promote murine erythroleukemia cell maturation [13] and trigger apoptosis in ATRA-sensitive and -resistant APL cell lines, and in blasts from patients with APL [14] . The present study aimed to understand mechanisms of WEB-2170-induced cytostasis and apoptosis in the APL cell line NB4, as well as to assess drug efficacy in other AML cell lines and, eventually, ex vivo in blasts from patients with different (M0 through M5) AML subtypes. The results reported herein show that WEB-2170 effects were mainly related to the enhanced expression of PTEN (phosphatase and tensin homologue, MMAC/TEP1) [15] , the product of a tumor suppressor gene that is lost or mutated in a number of human solid neoplasms [16, 17] , while still frequently conserved in myeloid leukemia [18, 19] . PTEN is known to counter the activity of the phosphatidylinositol 3-kinase (PI3K)/serine or threoninespecific protein kinase, PI3K/AKT, and extracellular signal-regulated kinase 2 (ERK2) signaling pathways that are implicated in the control of cell-cycle progression and apoptosis, and in leukemogenesis [20] . PTEN-mediated inhibition of PI3K/AKT and ERK pathways allows the translocation of the transcription factor forkhead box O3a (FOXO3a) to the nucleus [21] , thus promoting the selective expression of molecules involved in cell growth arrest and activation of apoptosis. Eventually, two facts supported the key role of PTEN in governing WEB-2170Àmediated effects: first, apoptosis occurred only in PTEN-positive AML cells and second, PTEN silencing in NB4 cells resulted in a significant reduction of drug efficacy.
Materials and methods
Cell lines, leukemic blasts, culture conditions, and assay for inverse agonist activity of WEB-2170 Different AML cell lines, namely KG1 (M1), NB4 (M3), NB4-MR4 (M3), THP1 (M5), and U937 (M5) have been employed. Culture conditions, cell counting, and viability were as reported previously [14] . Leukemic blasts from bone marrow aspirate and/or peripheral blood of 19 newly diagnosed AML patients with M0 through M5 subtypes were obtained after informed consent and according to the Ethics Hospital Committee guidelines (Helsinki declaration). Blasts and normal peripheral blood mononuclear cells were isolated by centrifugation on lymphocyte separation medium (Eurobio, Les Ulis Cedex, France) and then cultured as described for leukemia cell lines. Human embryonic kidney cells HEK293, stably transfected with PAFr were also used as the model to assess WEB-2170 inverse agonist activity as described previously [22] .
Reagents WEB-2170 [11] (Boehringer Ingelheim Pharma KG, Biberach, Germany) was dissolved in dimethyl sulfoxide (Sigma-Aldrich, St Louis, MO, USA) and stock solutions (512 mM) were stored at room temperature in the dark. The dimethyl sulfoxide vehicle did not interfere with WEB-2170 activities. All other chemicals employed were reagent grade.
RNA extraction, microarray analysis, and quantitative reverse transcriptase polymerase chain reaction (QRT-PCR) experiments
For details on methodologies and the primers used see Supplementary materials.
Cell lysate preparation, cell fractionation, sodium dodecyl sulfate polyacrylamide gel electrophoresis, and Western blotting Harvested cells were resuspended in a lysis buffer containing a cocktail of proteinase inhibitors (Calbiochem, Merck KGaA, Darmstadt, Germany), then sonicated and submitted to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) separation and Western blot as reported elsewhere [14] . Proteins from distinct subcellular compartments have been isolated by using the ProteoExtract Subcellular Proteome Extraction Kit (Calbiochem) as suggested by the manufacturer. Membranes were probed with primary antibodies against phospho-ERK1/2, ERK1/2, p53, PTEN, p21/WAF1, and a-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA, USA); phospho-AKT, AKT, and PARP (Cell Signaling Technology, Danvers, MA, USA); and FOXO3a and histone H4 (Upstate Biotechnology, Lake Placid, NY, USA and Millipore, Billerica, MA, USA). Horseradish peroxidaseÀconjugated IgG preparations were used as secondary antibodies; the electrochemiluminescence (ECL) procedure was employed for development.
Cell cycle analysis and determination of apoptosis Cell cycle distribution was determined by using the propidium iodide (PI)Àhypotonic citrate method with a FACScan flow cytometer (Becton-Dickinson, San Jose, CA, USA) [23] . Apoptosis was assessed either cytofluorimetrically by using the Annexin-VÀ Fluos/PI detection kit (Roche Molecular Biochemicals, Mannheim, Germany), or morphologically by examining stained cytosmears as reported previously [14] ; a microscope (Nikon Eclipse, mod. 50i) equipped with a digital camera (DS-5 M USB2) (Nikon Instruments, Florence, Italy) was employed.
PTEN silencing with small interfering RNA Exponentially growing NB4 cells were harvested, and approximately 2 Â 10 6 cells were electroporated with 100 mL human Nucleofector solution (Amaxa Biosystems, Gaithersburg, MD, USA) and 100 nM SMARTpool siRNA for PTEN (a mix of four small interfering RNA (siRNA) directed to different parts of human (GenBank accession no. NM_00314) PTEN mRNA (Dharmacon; cat. #M-003023-02), or 100 nM siCONTROL nontargeting siRNA no. 1 (Dharmacon; cat. #D-001206-13-05), by a Nucleofector instrument (Amaxa Biosystems) according to manufacturer's instructions. Transfection efficiency was 90%, as assessed in parallel with Cy3-labeled siGLO RISCfree siRNA. Immediately after electroporation, the cells were suspended in the complete medium and incubated for the indicated time with or without WEB-2170. Mock transfection was performed with the Nucleofector solution alone. 24 and 48 hours with or without 0.5 mM WEB-2170 to assess: (A) the % of propidium iodide (PI)Àstained NB4 cells in different phases of the cell cycle as determined by flow cytometry; (PI labeling, X-axis; total events, Y-axis). Cells with a DNA content !2 N (sub-G 1 fraction) were representative of an apoptotic population; (B) WEB-2170Àinduced time-dependent release of mitochondrial cytochrome C into the cytosol, and PARP cleavage, by Western blotting; a-tubulin was used to show equal sample loading. WEB-2170 caused an increase in PTEN protein, decrease in phospho-ERK2 and phospho-AKT, and induced nuclear translocation of FOXO3a, in NB4 cells treated as above. (C) Total cell extracts were analyzed by immunoblotting for PTEN, phospho-ERK1/2 and ERK1/2, phospho-AKT, AKT, p21/WAF1 and p53 protein; atubulin was used as the reference protein; (D) PTEN and FOXO3a protein partitioning in the cytosolic and nuclear fraction of NB4 cells at different times of incubation with/without the drug (see Materials and Methods). Histone H4 was also immunodetected at 48 hours to assess the purity of the isolated cellular compartments. Results were from a typical experiment out of three.
Statistical analysis
All data were statistically analyzed by Student's t-test. Significance was determined by analysis of variance followed by Newman-Keuls posttests using Prism version 4.0 (GraphPad software, San Diego, CA, USA).
Results
Gene expression profiling and QRT-PCR analysis of either untreated and WEB-2170-treated NB4 cells In order to define the transcriptome changes induced by WEB-2170 treatment, we assessed the gene-expression profile of NB4 cells incubated with/without 0.5 mM WEB-2170 for 24 hours was assessed using the Affymetrix HG-U133A GeneChip array. These data have been deposited in the Gene Expression Omnibus MIAME compliant public database (Supplementary Table E1 , online only, available at www.exphem.org). Using the filtering procedure described in Materials and Methods, we selected a list of 600 probesets as changing genes in all the four pair-wise comparisons between untreated and WEB-2170Àtreated NB4 cells (Supplementary Table E2 Conversely, the prevalent categories downregulated by WEB-2170 were negative regulation of apoptosis and positive regulation of cell proliferation. Next, we analyzed expression of genes involved in the regulation of cell growth and apoptosis. Gene-expression profiling data (Fig. 1A ) underlined the downregulation of positive regulators of cell-cycle progression, such as CCND2 (cyclin D2), MYB, and MYC, while growth-arrestÀrelated genes, such as the inhibitors of CDK/cyclin complexes CDKN1A (p21/Waf1) and CDKN2D (p19INK4D), GAS7, and CCNG2 (cyclin G2) were upregulated by WEB-2170. Furthermore, WEB -2170 determined the upregulation  of several proapoptotic genes, such as TNFÀa, lymphotoxin B, TRADD, CASP9, CASP8, NIX, and PTEN, while  some antiapoptotic genes including BCL2 were  downregulated. To validate microarray data, we carried out a quantitative reverse transcriptase polymerase chain reaction analysis on a set of differentially expressed selected genes (Fig. 1B) chosen on the basis of their biological function as master regulators of both proliferation and apoptosis. After a 24-hour treatment with WEB-2170, NB4 cells displayed a marked upregulation of cyclin G2 and p21/WAF1 and downregulation of cyclin D2 and antiapoptotic BCL2; concomitantly, expression of proapoptotic NIX, TNFÀa, and PTEN was significantly enhanced. These results were in keeping with those of microarray profiling and, notably, this trend was already evident at 15 hours of treatment (data not shown).
Inverse agonist activity of PAF-r ligand WEB-2170
The changes in gene expression described here led us to verify which might be the real pharmacologic effect of WEB-2170. In fact, the drug did not behave as a pure antagonist of PAF-r, as originally believed but, instead, as an inverse agonist of the receptor as reported for its analogue WEB-2086 [22] . Inverse agonists are described as having the opposite effect of pure agonists (such as PAF in this case) and being capable of sequestering with high affinity the inactive form of PAF-r and shifting the balance of active toward inactive PAF-r pool so as to significantly reduce the PAF-rÀmediated signal through G proteins. The assay was carried out by using HEK293 cells stably transfected with the PAF-r as the model according to procedures reported previously [22] ; our results showed that WEB-2170 acted as an inverse agonist for PAF-r by decreasing basal levels of inositol phosphate (IP) production (Fig. 1C) due to a significant decrease of the PAF-rÀmediated signal.
WEB-2170Àtreated NB4 cells undergo growth arrest in G 0 -G 1 and apoptosis Cells were incubated with or without 0.5 mM WEB-2170 and assayed for cell cycle progression. Cytofluorimetric analyses showed that approximately 66% and 77% of cells incubated with WEB-2170 for 24 and 48 hours, respectively, were arrested in G 0 -G 1 phase of the cell cycle; this was in line with the drug-mediated increased expression of p21/WAF1 and cyclin G2 observed at 24 hours (see Fig. 1B ). Concomitantly, there was a decrease in G 2 -M and S cell fraction, and at 48 hours the sub-G 1 fraction accounted for nearly half the treated population ( Fig. 2A) to denote the presence of apoptotic cells. This was confirmed by the time-dependent mitochondrial release of cytochrome C into the cytoplasm (Fig. 2B, top) , and by the cleavage of PARP after 48 hours of treatment (Fig. 2B, bottom) ; these data were in keeping with our previous observations on the cleavage of caspase 9, 8, and 3 [14] .
WEB-2170 induces PTEN increase, dephosphorylation of phospho-ERK2 and phospho-AKT, and nuclear translocation of FOXO3a Mechanisms of WEB-2170Àmediated apoptosis in NB4 cells were further been investigated by analyzing some of the proteins that play a major role in controlling cell growth and survival. Cells treated for 24 and 48 hours showed a time-dependent increase in PTEN accompanied by a rapid decline of phospho-ERK2 and phospho-AKT levels (Fig. 2C) . After 48 hours, WEB-2170 also caused a decrease in total AKT levels and an increase in p21/WAF1, while no changes in p53 levels were detected throughout the experiment. To evaluate whether the inhibition of the AKT and ERK pathway affected the intracellular distribution of FOXO3a, which is a substrate for both phospho-AKT [21] and phospho-ERK2 [24] , the nuclear and cytoplasmic fractions of NB4 cells at 9, 24, and 48 hours of treatment were isolated and analyzed separately. In treated NB4 cells, there was a progressive translocation of FOXO3a from the cytosol to the nucleus (Fig. 2D) , where it can exert its transcriptional activity, and this event associated with an increase in cytosolic PTEN and a decrease in both phospho-AKT and phospho-ERK levels. However, after 48 hours of treatment, PTEN translocated in part to the nucleus, where it may act as a proapoptotic factor [25] .
PTEN plays a crucial role in WEB-2170Àmediated apoptosis in AML cell lines In addition to NB4, other human AML cell lines such as KG1, NB4-MR4, THP-1, and U937 cells were tested at different times for their response to WEB-2170. Cytofluorimetric analysis with Annexin-V/PI confirmed that at 72 hours approximately 60% to 70% of treated NB4 cells were apoptotic. KG1 and NB4-MR4 cells were also sensitive to WEB-2170, yielding about 40% and 55% apoptotic cells, respectively, while THP1 and U937 cells seemed to be virtually unaffected by the drug (Fig. 3A) . A comparative cytofluorimetric analysis of NB4 and U937 cells after a 48-hour incubation period with/without WEB-2170 clearly showed the marked drug-induced apoptosis in NB4 cells but not in U937 cells (Fig. 3B) . The differential sensitivity of AML cell lines to druginduced apoptosis was explored further by measuring PTEN after 48 hours of incubation with/without WEB-2170. PTEN was expressed and upregulated by the drug in KG1, NB4, and NB4-MR4 cells, while it was absent in THP1 and U937 cells (Fig. 3C ) due to genetic alterations that hampered PTEN translation in U937 [18] and, probably, also in THP1 cells. The close relationship between PTEN expression, nuclear translocation of FOXO3a and apoptosis was confirmed by the fact that in PTEN-negative U937 cells that were resistant to WEB-2170Àinduced apoptosis, FOXO3a was always kept within the cytoplasm (Fig. 3D ).
PTEN silencing in NB4 cells by specific siRNA decreases drug-induced apoptosis To further investigate on the key role of PTEN in WEB2170Àmediated apoptosis, we employed PTEN-specific siRNA to inhibit PTEN expression in either untreated or drug-treated NB4 cells. PTEN silencing was effective in downregulating PTEN mRNA levels by approximately fivefold ( Supplementary Fig. E1 , online only, available at www.exphem.org). and decreasing PTEN protein levels (Fig. 4A) ; and, notably, decreased significantly WEB2170Àinduced apoptosis as compared to control siRNAtreated cells (Fig. 4B) . The mock-transfected cells showed no significant difference of apoptosis with respect to nontargeting siRNA-transfected cells.
WEB-2170 triggers apoptosis in blasts from patients with distinct AML subtypes Blasts from patients with different AML subtypes (M0 through M5; Fig. 5A ) were collected and incubated with or without 0.5 mM WEB-2170 for 48 hours. Blast sensitivity to drug-induced apoptosis, as quantified by the Annexin-V/PI assay (Fig. 5B) , was considerably high in all the samples, regardless of the specific AML subtype, and fell within a range of approximately 35% to 60% of cell population. The presence of apoptotic cells was a common morphologic finding in cytosmears of all the leukemic specimens following treatment (Fig. 5C ), but not of normal peripheral blood mononuclear cells (PBMC), which were apparently unaffected by the drug. Notably, WEB-2170Àtreated blasts from patient no.14 with AML (M4 subtype) showed an increase in PTEN protein and the mitochondrial release of cytochrome C (Fig. 5D ).
Discussion
This study demonstrated that WEB-2170 is a powerful antileukemic agent able to increase levels of PTEN protein, which plays a pivotal role in orchestrating the sequence of events that eventually commit AML cells to growth arrest and apoptosis. Microarray data provided strong molecular support to understand WEB-2170 effects in NB4 cells and traced the way for further investigation in other AML cell lines and blasts from AML patients. Upon addition of WEB-2170 in culture, NB4 cells underwent growth arrest in G 0 -G 1 and then a massive apoptosis. These findings were consistent with molecular biology results showing that WEB-2170 caused the downmodulation of several genes linked to cell proliferation and antiapoptotic pathways, while other genes promoting cell growth arrest, as well as the extrinsic and intrinsic apoptosis, were significantly upregulated. Apparently, the process was independent of p53 [26] and histone acetylation [13] . Moreover, we proved that WEB-2170 acts as an inverse agonist rather than an antagonist of PAF-r; this way, the drug induces the functional inactivation of PAF-r accompanied by a decrease in IP levels and this might be a critical metabolic event dictating the downstream inhibition of the PI3K/AKT signaling pathway.
However, besides these significant drug-induced modifications, we were interested in understanding the mechanisms whereby WEB-2170 prompted cytostasis/ apoptosis in AML cells and, possibly, identifying the key molecules governing these processes. Toward this end, it was crucial to discover that drug-induced apoptosis occurred only in AML cells where PTEN was expressed, but not in AML cells where PTEN was not translated. Based on these results, a possible mechanism of WEB-2170Àinduced apoptosis in PTEN-expressing AML cells might be as follows. The binding of WEB-2170 to PAF-r prompts the decrease of IP levels due to its inverse agonist activity, and the increase in cytoplasmic PTEN protein that exerts its dual phosphatase activity. The latter leads to indirect dephosphorylation of phospho-ERK2 [27] , that is also specifically inactivated by DUSP6 [28] , a phosphatase found to be upregulated by WEB-2170; and hydrolysis of the 3 0 -phosphate of the residual phosphoinositide PIP 3 to PIP 2 that contributes to depressing the PIK3/AKT-mediated signal and, in turn, promotes PTEN allosteric activation [29] . Under these conditions, both PI3K/AKT and ERK signaling pathways are negatively regulated and cannot cooperate to phosphorylate FOXO3a [24] that, once dephosphorylated, translocates from cytoplasm to the nucleus, where activates the transcription of several genes including those involved in cell growth arrest and apoptosis. Conversely, PTEN-lacking AML cells are resistant to WEB-2170Àinduced apoptosis and remain viable all through the treatment; also, in the absence of PTEN, FOXO3a is phosphorylated by phospho-AKT and phospho-ERK and kept in the cytosol, without translocating to the nucleus [30] . Importantly, results of in vitro experiments have been reproduced ex vivo in AML blasts, which responded well to WEB-2170Àinduced apoptosis, while normal PBMC were apparently drugresistant.
Overall, we demonstrated that WEB-2170 is a potent inhibitor of IP production and a positive regulator of PTEN in opposing the PI3K/AKT-and ERK2-mediated signaling pathways so as to induce growth arrest and apoptosis in AML cells. WEB-2170Àmediated upregulation of PTEN function might offer interesting translational opportunities to treat malignant myeloid disorders where the gene is still frequently conserved.
Supplemental material

RNA extraction and microarray analysis
Total RNA samples from two independent experiments for each condition (i.e., NB4 cells untreated and treated with 0.5 mM WEB-2170 for 24 hours) were extracted using RNeasy Mini kit (Qiagen, Valencia, CA, USA). Briefly, biotin-labeled target synthesis was performed, starting from 5 mg total cellular RNA, according to the protocol supplied by the manufacturer (Affymetrix, Santa Clara, CA, USA, http://www.affymetrix.com). Labeled cRNA was purified using Affymetrix GeneChip Sample Cleanup Module and fragmented (15 mg) as described in the Affymetrix GeneChip protocol. Disposable RNA chips (Agilent RNA 6000 Nano LabChip kit; Agilent Technologies, Waldbrunn, Germany, http://www.home.agilent.com) were used to determine the concentration and purity/integrity of RNA with the Agilent 2100 Bioanalyzer. The biotin-labeled target synthesis reactions, as well as the Affymetrix HG-U133A GeneChip arrays hybridization, staining, and scanning, were performed using Affymetrix standard protocols [1] . The Gene Chip Operating Software absolute analysis algorithm was used to determine the amount of a transcript messenger RNA (Signal), while the Gene Chip Operating Software comparison analysis algorithm was used to compare gene expression levels between two samples. Present genes were selected as the sequences showing the Detection call 'P' and Signal O100 in both the replicates of at least one condition. Differentially expressed genes were selected as the sequences showing a Change call 'I' or 'D' and Signal Log Ratio O1 or ! À 1 in the pair-wise comparisons between untreated and WEB-2170Àtreated NB4 cells. The gene list passing this filter was selected as ''changing genes.'' The DAVID (Database for Annotation, Visualization and Integrated Discovery) tool 2007 (http://david.abcc.ncifcrf.gov/) was used to examine selected lists of genes to identify over-representation of functional classes accordingly with gene ontology (GO) classification. All the data have been deposited in the Gene Expression Omnibus MIAME compliant public database, at http:// www.ncbi.nlm.nih.gov/geo (Supplementary Table E1 ).
Quantitative real-time polymerase chain reaction analysis
Complementary DNA was prepared from 1 mg total RNA, using Superscript II reverse transcriptase (Invitrogen). The relative quantity of D2, G2, NIX, BCL2, TNF-a and p21/WAF1 mRNA was measured using the Applied Biosystems 7500 Fast Real-Time PCR System, and determined by the comparative CT method using 18S rRNA as normalization gene. Amplification was performed with the default PCR setting: 40 cycles of 95 C for 15 sec and of 60 C for 60 sec using a SYBR Green based detection (SYBR Green Master mix; Applied Biosystems) and the following primers: for cyclin D2, forward 
